Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
PFE:USNew York

Pfizer Inc

COMPANY INFO
41.59USD
+0.12+0.29%
Market Closed
As of 08:04 PM EDT 05/20/2019 EDT
Open
41.40
Prev Close
41.47
Volume
23,009,069
Market Cap
231.237B
Day Range
41.2841.71
52 Week Range
35.3246.47
1D1M1Y5Y
View Full Chart
Market Closed
As of 08:04 PM EDT 05/20/2019 EDT
1D1M1Y5Y
View Full Chart
News
Press Releases
markets
Glaxo CEO Says Pfizer Joint Venture to Strengthen Pharma Pipeline
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio23.74
Bloomberg (BEst) P/E Ratio14.7273
Bloomberg (BEst) PEG Ratio2.8185
Shares Outstanding5.56B
Price to Book Ratio3.9314
Price to Sales Ratio4.4712
1 Year Return20.13%
30 Day Avg Volume23,533,192
EPS1.75
Bloomberg (BEst) EPS Curr Yr2.8990
Dividend3.46%
Last Dividend Reported0.36
Earnings Announcement for Period Ending Q2/2019:07/30/2019

Compare
1-Day Performance

-1%0+1%
-1%0+1%
Equity
PFE:US
+0.29%
Sponsored By

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Address
235 East 42nd Street New York, NY 10017 United States
Phone
1-212-733-2323
Website
www.pfizer.com

Income Statement

Quarterly
Annual
;
Q1 2019 (Billions USD)
  • Revenue
    13.0
  • Net Income
    4.0
  • Profit Margin
    29.61%

Balance Sheet

Quarterly
Annual
;
Q1 2019 (Billions USD)
  • Total Assets
    155.0
  • Total Liabilities
    96.0
  • Debt to Assets
    29.88%

Cash Flow

Quarterly
Annual
Q1 2019 (Billions USD)
  • Operating
    2.0
  • Investing
    8.0
  • Financing
    -8.0